Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice

Spinocerebellar ataxia type 3 (SCA3) is a genetic neurodegenerative disease for which a cure is still needed. Growth hormone (GH) therapy has shown positive effects on the exercise behavior of mice with cerebellar atrophy, retains more Purkinje cells, and exhibits less DNA damage after GH interventi...

Full description

Bibliographic Details
Main Authors: Yu-Te Lin, Yong-Shiou Lin, Wen-Ling Cheng, Jui-Chih Chang, Yi-Chun Chao, Chin-San Liu, An-Chi Wei
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/15/7974
_version_ 1797525601738817536
author Yu-Te Lin
Yong-Shiou Lin
Wen-Ling Cheng
Jui-Chih Chang
Yi-Chun Chao
Chin-San Liu
An-Chi Wei
author_facet Yu-Te Lin
Yong-Shiou Lin
Wen-Ling Cheng
Jui-Chih Chang
Yi-Chun Chao
Chin-San Liu
An-Chi Wei
author_sort Yu-Te Lin
collection DOAJ
description Spinocerebellar ataxia type 3 (SCA3) is a genetic neurodegenerative disease for which a cure is still needed. Growth hormone (GH) therapy has shown positive effects on the exercise behavior of mice with cerebellar atrophy, retains more Purkinje cells, and exhibits less DNA damage after GH intervention. Insulin-like growth factor 1 (IGF-1) is the downstream mediator of GH that participates in signaling and metabolic regulation for cell growth and modulation pathways, including SCA3-affected pathways. However, the underlying therapeutic mechanisms of GH or IGF-1 in SCA3 are not fully understood. In the present study, tissue-specific genome-scale metabolic network models for SCA3 transgenic mice were proposed based on RNA-seq. An integrative transcriptomic and metabolic network analysis of a SCA3 transgenic mouse model revealed that metabolic signaling pathways were activated to compensate for the metabolic remodeling caused by SCA3 genetic modifications. The effect of IGF-1 intervention on the pathology and balance of SCA3 disease was also explored. IGF-1 has been shown to invoke signaling pathways and improve mitochondrial function and glycolysis pathways to restore cellular functions. As one of the downregulated factors in SCA3 transgenic mice, IGF-1 could be a potential biomarker and therapeutic target.
first_indexed 2024-03-10T09:15:15Z
format Article
id doaj.art-b1c6a133a341441d9f2a92f7c662058a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T09:15:15Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b1c6a133a341441d9f2a92f7c662058a2023-11-22T05:41:20ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-012215797410.3390/ijms22157974Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic MiceYu-Te Lin0Yong-Shiou Lin1Wen-Ling Cheng2Jui-Chih Chang3Yi-Chun Chao4Chin-San Liu5An-Chi Wei6Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, TaiwanInstitute of ATP, Vascular and Genomic Center, Changhua Christian Hospital, Changhua 50091, TaiwanInstitute of ATP, Vascular and Genomic Center, Changhua Christian Hospital, Changhua 50091, TaiwanInstitute of ATP, Vascular and Genomic Center, Changhua Christian Hospital, Changhua 50091, TaiwanInflammation Research & Drug Development Center, Changhua Christian Hospital, Changhua 50091, TaiwanInstitute of ATP, Vascular and Genomic Center, Changhua Christian Hospital, Changhua 50091, TaiwanGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 10617, TaiwanSpinocerebellar ataxia type 3 (SCA3) is a genetic neurodegenerative disease for which a cure is still needed. Growth hormone (GH) therapy has shown positive effects on the exercise behavior of mice with cerebellar atrophy, retains more Purkinje cells, and exhibits less DNA damage after GH intervention. Insulin-like growth factor 1 (IGF-1) is the downstream mediator of GH that participates in signaling and metabolic regulation for cell growth and modulation pathways, including SCA3-affected pathways. However, the underlying therapeutic mechanisms of GH or IGF-1 in SCA3 are not fully understood. In the present study, tissue-specific genome-scale metabolic network models for SCA3 transgenic mice were proposed based on RNA-seq. An integrative transcriptomic and metabolic network analysis of a SCA3 transgenic mouse model revealed that metabolic signaling pathways were activated to compensate for the metabolic remodeling caused by SCA3 genetic modifications. The effect of IGF-1 intervention on the pathology and balance of SCA3 disease was also explored. IGF-1 has been shown to invoke signaling pathways and improve mitochondrial function and glycolysis pathways to restore cellular functions. As one of the downregulated factors in SCA3 transgenic mice, IGF-1 could be a potential biomarker and therapeutic target.https://www.mdpi.com/1422-0067/22/15/7974spinocerebellar ataxia type 3insulin-like growth factor 1RNA-seqcontext-specific metabolic networks
spellingShingle Yu-Te Lin
Yong-Shiou Lin
Wen-Ling Cheng
Jui-Chih Chang
Yi-Chun Chao
Chin-San Liu
An-Chi Wei
Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
International Journal of Molecular Sciences
spinocerebellar ataxia type 3
insulin-like growth factor 1
RNA-seq
context-specific metabolic networks
title Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
title_full Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
title_fullStr Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
title_full_unstemmed Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
title_short Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
title_sort transcriptomic and metabolic network analysis of metabolic reprogramming and igf 1 modulation in sca3 transgenic mice
topic spinocerebellar ataxia type 3
insulin-like growth factor 1
RNA-seq
context-specific metabolic networks
url https://www.mdpi.com/1422-0067/22/15/7974
work_keys_str_mv AT yutelin transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT yongshioulin transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT wenlingcheng transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT juichihchang transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT yichunchao transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT chinsanliu transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice
AT anchiwei transcriptomicandmetabolicnetworkanalysisofmetabolicreprogrammingandigf1modulationinsca3transgenicmice